BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21939917)

  • 1. Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study.
    Katsanos KH; Tatsioni A; Pedersen N; Shuhaibar M; Ramirez VH; Politi P; Rombrechts E; Pierik M; Clofent J; Beltrami M; Bodini P; Freitas J; Mouzas I; Fornaciari G; Moum B; Lakatos PL; Vermeire S; Langholz E; Odes S; Morain CO; Stockbrügger R; Munkholm P; Tsianos EV
    J Crohns Colitis; 2011 Oct; 5(5):430-42. PubMed ID: 21939917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal and Extraintestinal Cancers Associated With Inflammatory Bowel Disease.
    Chang M; Chang L; Chang HM; Chang F
    Clin Colorectal Cancer; 2018 Mar; 17(1):e29-e37. PubMed ID: 28712945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
    Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.
    Isene R; Bernklev T; Høie O; Munkholm P; Tsianos E; Stockbrügger R; Odes S; Palm Ø; Småstuen M; Moum B;
    Scand J Gastroenterol; 2015 Mar; 50(3):300-5. PubMed ID: 25535653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
    Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
    J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease.
    Lutgens M; Vermeire S; Van Oijen M; Vleggaar F; Siersema P; van Assche G; Rutgeerts P; Oldenburg B;
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):148-54.e1. PubMed ID: 25041864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN; Nugent Z; Blanchard JF
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
    Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of inflammatory bowel disease.
    Burisch J; Munkholm P
    Scand J Gastroenterol; 2015 Aug; 50(8):942-51. PubMed ID: 25687629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
    Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
    Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease in Iran: a review of 457 cases.
    Aghazadeh R; Zali MR; Bahari A; Amin K; Ghahghaie F; Firouzi F
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1691-5. PubMed ID: 16246187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
    Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001.
    Masala G; Bagnoli S; Ceroti M; Saieva C; Trallori G; Zanna I; D'Albasio G; Palli D
    Gut; 2004 Sep; 53(9):1309-13. PubMed ID: 15306591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Malignant Cancers in Inflammatory Bowel Disease.
    Loo SY; Vutcovici M; Bitton A; Lakatos PL; Azoulay L; Suissa S; Brassard P
    J Crohns Colitis; 2019 Sep; 13(10):1302-1310. PubMed ID: 30874294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study.
    Wolters FL; Russel MG; Sijbrandij J; Schouten LJ; Odes S; Riis L; Munkholm P; Langholz E; Bodini P; O'Morain C; Katsanos K; Tsianos E; Vermeire S; Van Zeijl G; Limonard C; Hoie O; Vatn M; Moum B; Stockbrügger RW;
    Scand J Gastroenterol Suppl; 2006; (243):46-54. PubMed ID: 16782622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.
    Vegh Z; Burisch J; Pedersen N; Kaimakliotis I; Duricova D; Bortlik M; Avnstrøm S; Vinding KK; Olsen J; Nielsen KR; Katsanos KH; Tsianos EV; Lakatos L; Schwartz D; Odes S; Lupinacci G; De Padova A; Jonaitis L; Kupcinskas L; Turcan S; Tighineanu O; Mihu I; Barros LF; Magro F; Lazar D; Goldis A; Fernandez A; Hernandez V; Niewiadomski O; Bell S; Langholz E; Munkholm P; Lakatos PL;
    J Crohns Colitis; 2014 Nov; 8(11):1506-15. PubMed ID: 24998983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.